Predicting nifedipine responses in preterm labor: a risk score incorporating ABCG2 polymorphisms and clinical factors
Jungsun Kim1, Ji Min Han2, Jeong Yee3
1College of Pharmacy, Kangwon National University, Chuncheon, Republic of Korea.
Background:
Nifedipine, a substrate of ATP-binding cassette superfamily G member 2 (ABCG2), is a tocolytic agent. This study aimed to construct a scoring system by exploring the association between ABCG2 polymorphisms and the treatment response of nifedipine in pregnant women.
Methods:
This study was conducted at a tertiary medical center. Eight single-nucleotide polymorphisms from the ABCG2 gene were selected. The adjusted OR (AOR) were calculated using multivariable analysis. A risk scoring system was constructed by dividing the AOR of independent risk factors by the minimum AOR to predict treatment failure.
Results:
A total of 69 patients were analyzed for treatment failure. Maternal age ≥33 years, contraction interval <4 minutes, and contraction intensity ≥20 mmHg were clinical risk factors associated with treatment failure. Patients with the ABCG2 rs2622604 and rs4148157 experienced an 8.6-fold and 4.3-fold increased risk of treatment failure, respectively. The predicted risks of treatment failure of patients who scored 0, 1-2, 3-4, 5-6, 7-8, and 9 points were 2.8%, 9.1%, 26.0%, 55.4%, 81.4%, and 93.9%, respectively.
Conclusion:
This novel risk scoring system may aid clinicians in identifying patients less likely to respond to nifedipine, improving individualized care in preterm labor management.
Related Concept Videos
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Factors Affecting Drug Response: Overview
Factors Influencing Drug Absorption: Presystemic Elimination


